Skip to main content
SpringerLink
Log in

Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the probability of death (POD) from any causes by time after diagnosis of non-small cell lung cancer (NSCLC) and the factors associated with survival for NSCLC patients.

Methods

A total of 202,914 patients with NSCLC from 2004 to 2013 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The overall survival (OS) and lung cancer-specific survival (LCSS) were calculated and POD from any causes at different time periods after diagnosis was explored. The predictive factors for OS, LCSS and survival from non-lung cancer deaths were investigated using multivariate analysis with Cox proportional hazards regression and competing risk regression analysis.

Results

The 5- and 10-year OS were 20.4% and 11.5%, accordingly that for LCSS were 25.5% and 18.4%, respectively. Lung cancer contributed 88.3% (n = 128,402) of the deaths. The POD from lung cancer decreased with time after diagnosis. In multivariate analysis, advanced age and advanced stage of NSCLC were associated with decreased OS and LCSS. Comparing to no surgery, any kind of resection conferred lower risk of death from lung cancer and higher risk of dying from non-lung cancer conditions except lobectomy or bilobectomy, which was associated with lower risk of death from both lung cancer and non-lung cancer conditions.

Conclusions

Most of the patients with NSCLC died from lung cancer. Rational surveillance and treatment policies should be made for them. Early stage and lobectomy or bilobectomy were associated with improved OS and LCSS. It is reasonable to focus on early detection and optimal surgical treatment for NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Aguilo R, Macia F, Porta M, Casamitjana M, Minguella J, Novoa AM (2008) Multiple independent primary cancers do not adversely affect survival of the lung cancer patient. Eur J Cardio Thorac Surg 34:1075–1080. doi:10.1016/j.ejcts.2008.08.004

    Article  Google Scholar 

  • Alexiou C et al (2003) Pneumonectomy for stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival. Ann Thorac Surg 76:1023–1028

    Article  PubMed  Google Scholar 

  • Butts CA et al (2010) Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol 28:29–34. doi:10.1200/jco.2009.24.0333

    Article  CAS  PubMed  Google Scholar 

  • Chen W et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132. doi:10.3322/caac.21338

    Article  PubMed  Google Scholar 

  • Colzani E, Liljegren A, Johansson AL, Adolfsson J, Hellborg H, Hall PF, Czene K (2011) Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics. J Clin Oncol 29:4014–4021. doi:10.1200/jco.2010.32.6462

    Article  PubMed  Google Scholar 

  • Donin N et al (2016) Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 122:3075–3086. doi:10.1002/cncr.30164

    Article  PubMed  Google Scholar 

  • Duchateau CS, Stokkel MP (2005) Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival. Chest 127:1152–1158. doi:10.1378/chest.127.4.1152

    PubMed  Google Scholar 

  • Eguchi T et al (2017) Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non-small-cell lung cancer: a competing risks analysis. J Clin Oncol 35:281–290. doi:10.1200/jco.2016.69.0834

    Article  PubMed  Google Scholar 

  • Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509

    Article  Google Scholar 

  • Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60:615–622 (discussion 622–613)

    Article  CAS  Google Scholar 

  • Groth SS, Rueth NM, Hodges JS, Habermann EB, Andrade RS, D’Cunha J, Maddaus MA (2010) Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer. Ann Thorac Surg 90:375–382. doi:10.1016/j.athoracsur.2010.04.100

    Article  PubMed  Google Scholar 

  • Hofmann HS, Neef H, Schmidt P (2007) Primary lung cancer and extrapulmonary malignancy. Eur J Cardio Thorac Surg 32:653–658. doi:10.1016/j.ejcts.2007.06.024

    Article  Google Scholar 

  • Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2016) SEER cancer statistics review, 1975–2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016

  • Hubbard MO, Fu P, Margevicius S, Dowlati A, Linden PA (2012) Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival. J Thorac Cardiovasc Surg 143:1307–1313. doi:10.1016/j.jtcvs.2012.01.078

    Article  PubMed  Google Scholar 

  • Janssen-Heijnen ML, Smulders S, Lemmens VE, Smeenk FW, van Geffen HJ, Coebergh JW (2004) Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 59:602–607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Janssen-Heijnen ML, van Erning FN, De Ruysscher DK, Coebergh JW, Groen HJ (2015) Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis. Ann Oncol 26:902–907. doi:10.1093/annonc/mdv061

    Article  CAS  PubMed  Google Scholar 

  • Johnson BE (1998) Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 90:1335–1345

    Article  CAS  PubMed  Google Scholar 

  • Jorgensen TL, Hallas J, Friis S, Herrstedt J (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106:1353–1360. doi:10.1038/bjc.2012.46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ketchandji M, Kuo YF, Shahinian VB, Goodwin JS (2009) Cause of death in older men after the diagnosis of prostate cancer. J Am Geriatr Soc 57:24–30. doi:10.1111/j.1532-5415.2008.02091.x

    Article  PubMed  Google Scholar 

  • Lu MS, Chen MF, Huang YK, Liu HP, Tsai YH (2016) Clinical outcome in lung cancer with a second malignancy: the time sequence matters. Medicine 95:e5203. doi:10.1097/md.0000000000005203

    Article  PubMed  PubMed Central  Google Scholar 

  • National Cancer Institute: Surveillance, Epidemiology, and end results. http://www.seer.cancer.gov. Accessed Apr 2016

  • Newschaffer CJ, Otani K, McDonald MK, Penberthy LT (2000) Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst 92:613–621

    Article  CAS  PubMed  Google Scholar 

  • Ng CS, Zhao ZR, Lau RW (2017) Tailored therapy for stage I non-small-cell lung cancer. J Clin Oncol 35:268–270. doi:10.1200/jco.2016.70.4718

    Article  PubMed  Google Scholar 

  • Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF (2004) Differential prognostic impact of comorbidity. J Clin Oncol 22:3099–3103. doi:10.1200/jco.2004.08.040

    Article  PubMed  Google Scholar 

  • Riihimaki M, Thomsen H, Brandt A, Sundquist J, Hemminki K (2012) Death causes in breast cancer patients. Ann Oncol 23:604–610. doi:10.1093/annonc/mdr160

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez M, Gomez MT, Jimenez MF, Aranda JL, Novoa N, Varela G (2013) The risk of death due to cardiorespiratory causes increases with time after right pneumonectomy: a propensity score-matched analysis. Eur J Cardio Thorac Surg 44:93–97. doi:10.1093/ejcts/ezs620

    Article  Google Scholar 

  • Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30. doi:10.3322/caac.21387

    Article  PubMed  Google Scholar 

  • Skaug K, Eide GE, Gulsvik A (2011) Predictors of long-term survival of lung cancer patients in a Norwegian community. Clin Respir J 5:50–58. doi:10.1111/j.1752-699X.2010.00200.x

    Article  PubMed  Google Scholar 

  • Son C, Lee SK, Choi PJ, Roh MS (2013) Characteristics of additional primary malignancies in Korean patients with non-small cell lung cancer. J Thorac Dis 5:737–744. doi:10.3978/j.issn.2072-1439.2013.11.23

    PubMed  PubMed Central  Google Scholar 

  • van der Drift MA et al (2012) Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol 7:291–298. doi:10.1097/JTO.0b013e31823a01fb

    Article  PubMed  Google Scholar 

  • Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Md JM (2016) Causes of death among cancer patients. Ann Oncol. doi:10.1093/annonc/mdw604

    Google Scholar 

  • Zhang Y, Sun Y, Wang R, Ye T, Zhang Y, Chen H (2015) Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer. J Surg Oncol 111:334–340. doi:10.1002/jso.23800

    Article  PubMed  Google Scholar 

  • Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76:2343–2350

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, First Hospital of Tsinghua University, No. 6, the First Road, Jiuxianqiao, Chaoyang District, Beijing, 100016, People’s Republic of China

    Shenhai Wei, Jintao Tian, Xiaoping Song & Bingqun Wu

  2. Department of Physiology, Capital Medical University, Beijing, 100069, People’s Republic of China

    Limin Liu

Authors
  1. Shenhai Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jintao Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoping Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bingqun Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Limin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shenhai Wei.

Ethics declarations

Funding

No funding.

Conflict of interest

Dr. Wei declares that he has no conflict of interest. Dr. Tian declares that he has no conflict of interest. Dr. Song declares that he has no conflict of interest. Dr. Wu declares that he has no conflict of interest. Dr. Liu declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, S., Tian, J., Song, X. et al. Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database. J Cancer Res Clin Oncol 144, 145–155 (2018). https://doi.org/10.1007/s00432-017-2522-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-017-2522-3

Keywords

Search

Navigation